Latest Financial Outlook News

Aroa Biosurgery reaffirms strong FY26 guidance, buoyed by favourable US Medicare reimbursement for Symphony and promising trauma study results for Myriad.

Xero Limited reveals new AI product demonstrations and updates on Melio’s integration, reaffirming ambitious US growth and FY28 revenue targets.

Stavely Minerals has initiated an updated 2026 Scoping Study for its Stavely Project, reflecting significantly improved metal prices and exploration results that extend gold mineralisation across multiple prospects.

5E Advanced Materials has resumed trading on the ASX following its announcement of a proposed capital raising through a U.S. public offering. Investors await details on how this move will reshape the company’s financial outlook.

Clime Investment Management appoints John Abernethy as Director of Investments, signalling a renewed focus on investment philosophy and client outcomes. Despite fund closures and regulatory challenges, the company reports improved fund returns and a promising interim profit outlook.

Cobalt Blue Holdings has enhanced the financial outlook for its Kwinana Cobalt Refinery project, secured a $5.3 million capital raise, and advanced key environmental and feedstock initiatives amid a tightening cobalt market.

Stavely Minerals is advancing its 2026 Scoping Study for the Stavely Copper-Gold Project, targeting a significant production scale boosted by strong copper, gold, and silver prices. The company aims to outline a pathway to over 10 years of mine life with a mid-year study delivery.

Lunnon Metals has secured unconditional status for its Ore Purchase Agreement with Gold Fields and approved mining at Lady Herial, backed by a robust feasibility study projecting strong cash flows. Exploration continues aggressively across its gold and nickel projects in Western Australia.

betr Entertainment reported a $13.2 million EBITDA loss in H1 FY26 due to strategic investments and favourable customer outcomes but projects a strong rebound with a $13-19 million EBITDA target for FY27.

Bannerman Energy reported a strong cash position of AUD 89.3 million at the end of December 2025, supported by significant equity financing and ongoing exploration investments. The company’s funding runway now extends to over nine quarters, providing a solid buffer for its uranium exploration activities.

Microba Life Sciences reports robust year-on-year growth in microbiome testing volumes and revenue, advancing towards regional break-even in Australia and the UK while progressing its therapeutic pipeline.

Perpetual Limited’s second quarter FY26 update reveals a mixed performance with strong Corporate Trust growth balancing net outflows in Asset Management, while Wealth Management remains stable amid ongoing sale talks.